Median Screatadm was 84 [59, 150] μmol/l, median Gal-3 dosage was 21 [14.2, 33] ng/ml, median plasma NGAL (pNGAL) was 209 [97, 506.8] μg/l and 774 (37.3%) patients had AKI. Here, LCN2 is linked to acute kidney injury.